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oeview questionEsF
The overall aim of this review is to provide guidance as to which of the existing exercise and behavioural
interventions appear most promising for the treatment of Mp fatigue. The specific objectives are toW
ENF mrovide a narrative synthesis of all the interventions including a breakdown of the key contextual and treatment
components of each of the interventionsI the acceptability of the interventions Euptake and adherenceFI and the study
quality Erisk of biasF alongside the standardized intervention effect sizes.
E2F Conduct metaJanalyses of effect sizes across interventions with similar key intervention components.
EPF Compare the overall effect sizes of the exercise and behavioral interventions followed by subgroup analysis within
each of these groups Ee.g. behavioral interventionsW energy conservationI CBTI combined; exercise interventionsW
aerobic enduranceI strengthI balance and combinedF.
E4F Conduct exploratory moderator and sensitivity analyses to explore how treatment effects vary according to
whether interventions were guided by theory or notI different levels of health care professional contact Ee.g. email
supportI telephoneI faceJtoJfaceFI types of MpI comparators usedI and study quality.
pearches
The following data sources will be searchedW
Cumulative fndex to kursing and Allied eealth iiterature ECfkAeiFI
bxcerpta Medica aataBase EbMBApbFI
msycfkclI
MbaifkbI
Allied and Complementary Medicine aatabase EAMbaFI
iatinJAmerican and Caribbean Centre on eealth pciences fnformation EiiiACpFI 
mhysiotherapy bvidence aatabase EmeaooFI
pmloTaiscusI 
teb of pcienceI and
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The Cochrane Central oegister of Controlled Trials ECbkToAiF.
oeference lists and citations of included studies and previous Mp fatigue reviews.
Trial registersW Cochrane iibraryI tel fCTomI kfeoI ClinicalTrials.govI ControlledJtrialsI aissertation Abstracts
fnternational torld CatI dreylit.orgI and lpen drey.
fn additionI there will be contact with experts in the field.
There will be no language restrictions or date restrictions imposed.
Additional information about the search strategy can be found in the attached mac document.
Types of study to be included
oandomised controlled trials EoCTsF or controlled clinical trials ECCTsF of any behavioural andLor exercise
intervention for multiple sclerosis EMpF including parallel groupI crossover and cluster trials. A study will be labelled
CCT where the allocation mechanism is not truly random Ei.e. quasiJrandomisationF or is unclear in the manuscript.
Condition or domain being studied
Multiple sclerosis EMpF is a chronic inflammatoryI demyelinating and neurodegenerative disease of the central
nervous system ECkpF Ehingwell et al.I 2MNPF. catigue affects around 9M% of people with Mp EpwMpFI with over twoJ
thirds reporting it is their most troubling symptom EdiovannoniI 2MMSF.
hingwell bI MarriotI gg et al. E2MNPF. "fncidence and prevalence of multiple sclerosis in buropeW a systematic review."
BMC keurology NPENFW N28. 
diovannoniI d E2MMSF. "Multiple sclerosis related fatigue." gournal of keurologyI keurosurgery C msychiatry TTENFW
2JP.
marticipantsL population
Adults Eaged N8 and overF with a confirmed diagnosis of multiple sclerosis EMcaonald 2MMN; molman 2MMR; molmanI
2MNNF including all disease subgroups Erelapsing remittingI secondary progressive and primary progressive multiple
sclerosisF. ptudies which include people with Mp together with people with other medical conditions will be included
if data for the Mp group are reported separately. there data for participants with Mp are not reported but studies
contain a heterogeneous sample with at least RM% of participants with Mp we will contact the authors to try to obtain
the results for the Mp subgroup.
fnterventionEsFI exposureEsF
The intervention should be clearly defined as a behavioural or exercise fatigue intervention. cor the purposes of this
review a behavioural intervention is one that aims to result in behaviouralI lifestyleI or attitudinal changes and may
include changes in physical activity. Behavioural interventions are broad rangingI typically incorporating selfJ
management aspects and may include energy conservationI relaxationI mindfulness trainingI CBTI educational
strategiesI and multimodal approaches. An exercise intervention is one that primarily aims to increase lifestyle
physical activity or introduce structured exercise but may also include components of behavioural interventions.
mhysical activity is defined as any bodily movement produced by skeletal muscles that requires energy expenditure
and includes exercise as well as other activities which involve bodily movement and are done as part of playingI
workingI active transportationI house chores and recreational activities EtelI
httpWLLwww.who.intLtopicsLphysical_activityLenLF. bxercise is defined as a subcategory of physical activity that is
plannedI structuredI repetitiveI and purposeful in the sense that improvement or maintenance of one or more
components of physical fitness is the objective EtelI httpWLLwww.who.intLmediacentreLfactsheetsLfsP8RLenLF.
bxercise interventions are also varied and include structured exercise Esuch as aerobicI strength and conditioning
trainingFI balance interventionsI active gaming interventions Esuch as ubox hinectI kintendo tiiFI mindJbody Esuch
as yogaI Tai ChiLni dongFI danceI waterJbased Esuch as aquatic exerciseFI other lifestyle physical activityI
combinations of exercise as well as components of behavioural interventions.
ComparatorEsFL control
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The comparator could include no interventionI usual careI standard medical careI placebo treatment or another active
intervention.
Context
fncluded interventions may vary in duration and take place in the hospitalI in the communityI at home or some
combination and could be selfJdirected or supervised or a combination. fnterventions may be delivered faceJtoJfaceI
or via the internetI pMAoT deviceI teleJ or videoJconferenceI in groups or oneJtoJone or in some combination.
fnterventions will be excluded if they do not clearly define the intervention as a fatigue intervention andLor do not
measure fatigue severity andLor impact of fatigue as an outcome. mharmacological and dietary studies will be
excluded except where diet is included as part of a broader behavioural approach.
lutcomeEsF
mrimary outcomes
catigue severity andLor impact of fatigue measured using a validated uniJ or multidimensional selfJreport fatigue scale
Esuch as the catigue peverity pcale Ehrupp et al.I N989FI the Modified catigue fmpact pcale EmsAI N998FI The
Chalder catigue pcale EChalder et al.I N99PFI the keurological catigue fndex EMills et al.I 2MNMFI The molMfp short
form ECook et al.I 2MN2FI the Checklist fndividual ptrength Esercoulen et al.I N99SFI visual or numerical rating scales
or an appropriate validated subscale of broader instruments Esuch as the sitality subscale of the pcPS Etare and
pherbourneI f992F.
catigue severity andLor impact of fatigue at postJintervention. mostJintervention is defined as within two months
following the stated duration of the intervention.
pecondary outcomes
pelfJreported fatigue severity andLor impact of fatigue Eas measured aboveF at followJup. fn additionI any broadly
relevant physical or cognitiveLmental fatigability measures will be extracted. catigability has been defined as “the
magnitude or rate of change in a performance criterion relative to a reference value or given time of task performance
or measure of mechanical output” EhlugerI hruppI C bnokaI 2MNPI p.4NNF. Measures of performance fatigue may be
defined as decrements in performance in voluntary activationI strengthI power and endurance during sustained tasks.
The cognitive domain of fatigability has been measured as “declines in either reaction time of accuracy over time on
continuous performance tasksI or a probe task given before and immediately after a fatiguing cognitive task” EhlugerI
hruppI C bnokaI 2MNPI p.4N4F.
hlugerI BMI hruppIiB et al. E2MNPF. "catigue and fatigability in neurologic illnesses proposal for a unified
taxonomy." keurology 8ME4FW 4M9J4NS.
catigue severity andLor impact of fatigue measured at PJS and >S months followJup. Cognitive or physical fatigability
measured at postJtreatmentI PJS and >S months followJup.
aata extractionI Eselection and codingF
All titles and abstracts will be reviewed by two independent reviewers. The full paper review will be conducted by
two independent reviewers. Coding and data extraction will be performed by two independent reviewers using a data
extraction tool developed a priori based on the Cochrane eandbook recommendations. The additional data extraction
for the process analysis based on the Tfaieo duidance Eeoffmann et al 2MN4F will be singleJextracted. All
discrepancies will be discussed between the two reviewers and the team will be consulted if a consensus cannot be
met.
aata to be extracted will includeW ptudy faI dateI country and clinical settingI study designI rationale of studyI
eligibility criteriaI participant characteristics Ee.g. ageI genderI years since diagnosisI type of MpI degree of
disabilityFI flowchart of participants through all stages of studyI description of interventionI basic intervention costs if
availableI description of comparison groupEsF Comparability of baseline characteristics between treatment and control
arms Enumber enrolled in trial and each groupI presence of sample size calculationI numbers included at each followJ
up and reasons for drop and withdrawalI attempts at maskingI description of randomisationI allocation concealment
and description of followJupF. lutcome measuresI timing of outcome administrationLmeasurementI whether intentionJ
toJtreat EfTTF analysis was undertakenI secondary outcomes included such as quality of life and mood and whether
positive effects were reported for the secondary outcomesI for nominal outcomes Edenominator and numerator in each
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category for each groupFI for interval and ordinal data EkI meanI pa for each groupF or EkI medianI fno or rangeF as
appropriate.
The intervention component analysis will be based in part on Tfaieo duidance Eeoffmann et al.I 2MN4F. This will
includeW 
N. Brief name and description of intervention. 
2. thy? aescribing any rationaleI theory xmodel of Mp fatigue] or goal of the elements essential to the Mp
intervention. 
P. that? MaterialsW aescribing any physical or standardised informational materials used in the interventionI
including those provided to participants or used in intervention delivery or in training of intervention providers. ff
materials are availableI provide information on where the materials can be accessedI such as website for participantsI
author’s websiteI online appendixF. 
4. that? mroceduresW aescribing each of the component proceduresI activitiesI andLor processes used in the
interventionI including any enabling or support activities. This includes categorising the type of interventionI and
listing the intervention components or treatment processes.
R. tho provided? cor each category of intervention provider Esuch as psychologistI nursing assistantFI describing
their qualificationLexpertiseI backgroundI and any specific training given. 
S. eow? aescribing the modes of delivery Esuch as face to face or by some other mechanismI such as internet or
telephoneF of the intervention and whether it was provided individually or in a group. 
T. there? aescribing the typeEsF of locationEsF where the intervention occurred Ee.g. hospitalI communityI homeJ
based settingFI including any necessary infrastructure or relevant features. 
8. then and how much? aescribing the number of times the intervention was delivered and over what period of time
including the number of sessionsI their scheduleI and their durationI intensityI or dose. fn additionI describing how
much homework or between sessions activity has been prescribedI relative to inJsession activity completed with the
health care professional or researcher. 
9. TailoringW ff the intervention was planned to be personalisedI titrated or adaptedI then describe whatI whyI whenI
and how. 
NM. ModificationsW ff the intervention was modified during the course of the studyI describe the changes EwhatI whyI
whenI and howF. 
NN. eow well? mlannedW ff therapist fidelityLadherence was assessedI describing how and by whomI and if any
strategies were used to maintain or improve fidelityI describe them. ActualW ff therapist fidelityLadherence was
assessedI describing the extent to which the intervention was delivered as planned. 
N2. eow well? marticipant AdherenceW ff participant adherence was assessedI describing how and by whomI and if any
strategies were used to maintain or improve participant adherence. 
eoffmannI T. C. and M. c. talker E2MNRF. "TfaieoJing up’ the reporting of interventions in stroke researchW the
importance of knowing what is in the ‘black box." fnternational gournal of ptroke NMERFW SRTJSR8.
oisk of bias EqualityF assessment
oisk of bias EolBF will be assessed by two independent reviewers according to the Cochrane eandbook for
pystematic oeviews of oisk of Bias tool Eeiggins 2MNNFI includingW random sequence generationI allocation
concealmentI blinding EparticipantsI personnel and outcome assessorsFI incomplete outcome dataI selective outcome
reporting and other potential sources of bias. 
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eiggins gmI Altman adI dotzsche mCI guni mI Moher aI lxman AaI pavovic gI pchulz hcI teeks iI pterne gAI
Cochrane Bias Methods droup; Cochrane ptatistical Methods droupW The Cochrane Collaboration’s tool for assessing
risk of bias in randomised trials. BMg. 2MNNI P4PW dR928JNM.NNPSLbmj.dR928.
ptrategy for data synthesis
mlanned quantitative analyses. there data are available from more than one study of a particular intervention we will
pool results from these in a metaJanalysis for each outcome with comparisons between relevant intervention and
comparator groups for behaviouralI exercise and combined interventions to determine overall effect using a random
effects estimate. The decision to pool data will be based on the detailed intervention component analysis. there
insufficient data are available or where clinical and methodological heterogeneity means that it is not possible to pool
results in metaJ analysis we will present individual study estimates of effect and conduct a narrative synthesis Emopay
et al.I 2MMSF. Measures of treatment effect. there studies use the same type of interventionI comparator and type of
outcomeI we will pool the results using random effects metaJanalysis with mean differences or standardised mean
differences for continuous measures or risk ratios for dichotomous outcomes. there there are multiple intervention
groups within a trialI we will combine all relevant data from multiple intervention or multiple control groups into a
single intervention or control group to avoid multiple counting of participant data. fn studies where the effects of
clustering have not been taken into accountI and where inter cluster correlation EfCCF coefficients have been reportedI
we will adjust the standard deviations for the design effect to avoid unit of analysis errors. fn the case of crossover
trials we will assess the risk of bias associated with the suitability of the design and the potential for a carryover effect
following behavioural or exercise interventions. there bias is judged to be minimal analysis of data will be
conducted using a paired analysis EblbourneI 2MM2F where possible or where this information is not availableI only
data up to the point of first crossover will be used for analysis. eeterogeneity will be classified using the thresholds
given in the Cochrane handbook
httpWLLhandbook.cochrane.orgLchapter_9L9_R_2_identifying_and_measuring_heterogeneity.htm. Analyses will
examine sources of heterogeneity. te will conduct sensitivity analyses based on study quality. te will use stratified
metaJanalyses to explore heterogeneity in effect estimates according toW study quality; study populations; the logistics
of intervention provision; and intervention content. te will also assess evidence of publication bias.
Analysis of subgroups or subsets
The main analysis will be based on total effect for all the behavioural studies and one for the exercise studiesI and
planned subJgroup analyses based on grouping subJtypes within these categories Ee.g. bnergy conservationI CBTI
combined; aerobic enduranceI resistanceI balanceI flexibility and combinationF with any type of comparator group
Ei.e. active or inactive controlsF. bxploratory moderator and sensitivity analyses will include health care professional
contact EeCmF compared to no or limited eCm contact Ee.g. session dosageFI type of Mp ErelapsingJ remitting versus
more progressive forms of MpFI studies comparing interventions to active placebo comparators and treatment as usual
Ee.g. exercise vs noJexercise controlFI and low or high study quality based on the ooB assessmentI non randomised
trials and randomised trials.
aissemination plans
The findings will be initially presented to the Mp pociety rh Clinical Trial ketwork ECTkF catigue working group
Ewhich includes service usersF for feedback. This will be followed by a stakeholder event. The purpose of the event is
to present the findings from the review to people with Mp EpwMpFI health care providers including neurologistsI Mp
specialist nursesI occupational therapistsI physiotherapistsI psychologists and if possible commissioners. cinallyI a
condensed version of the final report will be submitted for publication in a peerJreviewed scientific journal. The data
will also be presented at relevant conferences.
Contact details for further information
mrofessor oona MossJMorris
eealth msychology pectionI fnstitute of msychiatryI msychology and keuroscience
hingDs College iondon 
Rth cloor Bermondsey ting
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duyDs eospitalI dreat Maze mond
pbN 9oT
rona.mossJmorris@kcl.ac.uk
lrganisational affiliation of the review
eealth msychology pectionI fnstitute of msychiatryI msychology and keuroscienceI hingDs College iondon and pchool
of eealth pciencesI nueen Margaret rniversityI Musselburgh.
httpWLLwww.kcl.ac.ukLioppnLdeptsLpsychologyLresearchLoesearchdroupingsLhealthpsychLindex.aspx and
httpWLLwww.qmu.ac.ukLhsL
oeview team
mrofessor oona MossJMorrisI eealth msychology pectionI fnstitute of msychiatryI msychology and keuroscience
mrofessor Tom MercerI pchool of eealth pciencesI nueen Margaret rniversity
ar Claire thiteI eealth and pocial Care oesearch aivisionI caculty of life pciences C MedicineI hingDs College
iondon
ar parah ThomasI Bournemouth rniversity Clinical oesearch rnitI caculty of eealth and pocial pciencesI
Bournemouth rniversity
ar Marietta san de iindenI Centre for eealthI Activity and oehabilitation oesearchI nueen Margaret rniversity
ar Anthony earrisonI eealth msychology pectionI fnstitute of msychiatryI msychology and keuroscience
ar oeza pafariI Centre for eealthI Activity and oehabilitation oesearchI nueen Margaret rniversity
ar pam kortonI eealth msychology pectionI fnstitute of msychiatryI msychology and keuroscience
Collaborators
ar gane mettyI matient and mublic fnvolvement Member
Ms ptephanie eannaI matient and mublic fnvolvement Member
Anticipated or actual start date
MN aecember 2MNR
Anticipated completion date
MN lctober 2MNS
cunding sourcesLsponsors
Multiple pclerosis pociety rh EAward oeferenceW 2SF.
Conflicts of interest
Two members of the review teamI mrofessor oona MossJMorris and ar parah Thomas have published randomised
controlled trials of behavioural interventions for fatigue in multiple sclerosis which meet the inclusion criteria of the
current review. mreliminary searchesI formal screening of search results against eligibility criteriaI data extractionI
risk of bias assessment and data analysis will be conducted independently of these individuals.
ianguage
bnglish
Country
bnglandI korthern frelandI pcotlandI tales
pubject index terms status
pubject indexing assigned by Coa
pubject index terms
bxercise; bxercise Therapy; catigue; eumans; Multiple pclerosis; mhysical Therapy Modalities; Treatment lutcome
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aate of registration in molpmbol
NS May 2MNS
aate of publication of this revision
MS gune 2MNS
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mreliminary searches ko   ves 
miloting of the study selection process   ko   ves 
cormal screening of search results against eligibility criteria   ves   ko 
aata extraction   ves   ko 
oisk of bias EqualityF assessment   ves   ko 
aata analysis   ko   ko 
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